St. Jude Medical Announces Fourth Quarter Dividend

Board of Directors declare fourth quarter dividend of $0.29 per share

ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced that its Board of Directors declared a fourth quarter dividend of $0.29 per common share of the Company’s stock. This dividend amount is equal to the dividend paid during the first, second and third quarters of 2015 and brings the total dividend declared for the year to $1.16 per share. The dividend is payable January 29, 2016, to shareholders of record at the close of business on December 31, 2015.

About St. Jude MedicalSt. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases. The company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical has four major clinical focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit sjm.com or follow us on Twitter @SJM_Media.

Forward-Looking StatementsThis news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company’s control and the risk factors and other cautionary statements described in the Company’s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company’s Annual Report on Form 10-K for the fiscal year ended January 3, 2015 and Quarterly Report on Form 10-Q for the fiscal quarter ended October 3, 2015. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151207006411/en/

St. Jude Medical, Inc.
J.C. Weigelt, 651-756-4347
Investor Relations
[email protected]
or
Candace Steele Flippin, 651-756-3029
Media Relations
[email protected]

Source: St. Jude Medical, Inc.

You May Also Be Interested In

• Faraday Future signs robotics distributor deal, plans partner event
• Breeze Acquisition Corp. II gets Nasdaq notice for late 10-Q filings
• Andersen closes secondary offering of 4.9M shares at $44 each